HIV Policy & Advocacy
AIDS 2016: Neglect of Infectious Disease in Prisons Highlighted at Conference
- Details
- Category: HIV/AIDS Epidemiology & Mortality
- Published on Wednesday, 07 September 2016 00:00
- Written by Theo Smart
A special issue of The Lancet was published to coincide with the recent 21st International AIDS Conference in Durban, containing a comprehensive seriesof reviews on the burden of HIV, hepatitis B, hepatitis C, and tuberculosis (TB) among prisoners worldwide.
FDA Taking Public Comment on Potential Changes to Gay Blood Donation Policy
- Details
- Category: HIV Policy & Advocacy
- Published on Friday, 02 September 2016 00:00
- Written by Liz Highleyman
Through late November the U.S. Food and Drug Administration (FDA) is currently accepting public comments, supported by scientific evidence, as it considers changes to its policy restricting blood donations by gay and bisexual men. Instead of the current 1-year waiting period after a man has sex with another man, the agency is considering a more individualized policy that focuses on risk behavior rather than sexual orientation or self-identification.
AIDS 2016: San Francisco Sees Progress in Getting to Zero Initiative
- Details
- Category: HIV Policy & Advocacy
- Published on Thursday, 01 September 2016 00:00
- Written by Liz Highleyman
San Francisco continues to make good progress with its "Getting to Zero" initiative, which aims to achieve the triple goal of zero new HIV infections, zero AIDS deaths, and zero stigma for people living with HIV. But not all groups are doing equally well, according to a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban.
AIDS 2016: Earlier HIV Treatment Is Not Over-burdening Health Services
- Details
- Category: Global Access
- Published on Thursday, 01 September 2016 00:00
- Written by Keith Alcorn
Earlier antiretroviral treatment initiation is not overwhelming rural health services in South Africa, but changes in treatment eligibility criteria alone may not be enough to increase the number of people on treatment substantially, and more investment will be needed in testing and linkage to care to reach treatment coverage goals, research presented at the recent 21st International AIDS Conference (AIDS 2016) shows.
AIDS 2016: Infection Prophylaxis Reduces Risk of Death for People Starting HIV Treatment Late
- Details
- Category: Global Access
- Published on Tuesday, 23 August 2016 00:00
- Written by Keith Alcorn
A package of enhanced prophylaxis against infections significantly reduced the risk of death for adults and children with advanced HIV disease after starting antiretroviral treatment in a randomized study, James Hakim from the University of Zimbabwe reported at the 21st International AIDS Conference (AIDS 2016) last month in Durban. Another analysis showed that intensifying treatment by adding raltegravir did not offer added benefits.
More Articles...
- AIDS 2016: Reducing Clinic Visits Supports Retention in HIV Care, African Studies Show
- AIDS 2016: HIV Criminalization on the Rise, Especially in Sub-Saharan Africa
- AIDS 2016: HIV Stigma Persists in the Undetectable Era
- AIDS 2016: Progress Towards 90-90-90 Targets is Promising, But Funding Is the Critical Step
Web Design and Development by